Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart FRx automated external defibrillators

Philips announces collaboration with American Telemedicine Association to further commitment to telehealth

Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers

Spire

Unitil

The S&P 500’s annual earnings per share increased about 7.2% every year over the past five years through Dec.

A Trio of Stocks Growing Earnings Fast

Ford Motor Company

ResMed

Amid the pandemic crisis, the ventilator industry gains on contributions from companies across various sectors.

Ventilator Industry Pumps Up Amid Coronavirus: 3 Stocks in Focus

Philips Lumify handheld ultrasound solution launched in Japan to enable powerful diagnostics at the bedside

FDA issues Emergency Use Authorization for Philips’ new acute care patient monitoring solutions for hospital-based remote monitoring

Philips Foundation publishes its 2019 Annual Report

Masimo

Masimo and Philips licensing agreement brings Masimo NomoLine® Capnography and O3® Regional Oximetry to select Philips patient monitors

Philips launches next generation wearable biosensor for early patient deterioration detection, including clinical surveillance for COVID-19

Philips launches HealthSuite Clinical Trial Accelerator to help life science organizations run more flexible, patient-centric clinical trials

Philips receives FDA clearance for the use of its ultrasound portfolio to manage COVID-19-related lung and cardiac complications

Philips to convene Extraordinary General Meeting of Shareholders

Philips first of its kind ultrasound solution for pediatric assessment provides a gentler approach to imaging children

FDA lifts injunction on manufacture and distribution of Philips’ defibrillators in the US

Philips: Strong Earnings Report Reveals Clear Pathway For Growth

Koninklijke Philips N.V. (PHG) CEO Frans van Houten on Q1 2020 Results - Earnings Call Transcript

Koninklijke Philips' (PHG) Q1 results reflect the impact of COVID-19 pandemic despite robust performances in the Diagnosis & Treatment and Connected Care businesses.

Koninklijke Philips' (PHG) Q1 Earnings Down on Coronavirus Impact

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Royal Philips (PHG) Stock?

Philips teams with University of Kentucky's UK HealthCare to power state’s only eICU Clinical Command Center

As of late, it has definitely been a great time to be an investor in Koninklijke Philips.

Koninklijke Philips' Shares March Higher, Can It Continue?

Philips details plans to increase its hospital ventilator production to 4,000 units/week by Q3 2020, and introduces its new Philips Respironics E30 ventilator with an immediate production of 15,000 units/week

Cadence Design Systems

CrowdStrike

ManTech

Science Applications International

A closer look into the technology sector reveals that a few  stocks from this sector have actually skyrocketed in the past month defying coronavirus-induced mayhem.

5 Top Tech Stocks Rallying Over 20% Amid Coronavirus Crisis

Cardinal Health

Chemed

Dropbox

Enphase Energy

Although the death toll continues to go up in the United States, the curves related to hospitalization, intensive-care check-ins and intubations are gradually flattening.

U.S. Economy Likely to Reopen in May: 5 Top Growth Picks

KLM and Philips to set up a special freight airlift from Amsterdam to China

News for Royal Philips Stock (PHG)